CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study. - Pariser, David M.; Lebwohl, Mark G.; Jaworski, Janusz; Trefler, Jakub; Daniluk, Stefan; Dudek, Anna; Baran, Wojciech; Owczarek, Witold; Brzewski, Pawel; Sikora, Mariusz; Krogulec, Marek; Kim, SungHyun; et al. (Dermatology & Therapy, 2025)